EP4724152A1 - Antiperspirant composition - Google Patents
Antiperspirant compositionInfo
- Publication number
- EP4724152A1 EP4724152A1 EP24731512.0A EP24731512A EP4724152A1 EP 4724152 A1 EP4724152 A1 EP 4724152A1 EP 24731512 A EP24731512 A EP 24731512A EP 4724152 A1 EP4724152 A1 EP 4724152A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition
- antiperspirant
- composition according
- surfactant
- aluminium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/28—Zirconium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K8/894—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/31—Anhydrous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/58—Metal complex; Coordination compounds
Definitions
- the present invention relates to an antiperspirant composition.
- the invention particularly relates to an antiperspirant composition for reducing stains on fabrics.
- astringent metal salts such as aluminium or zirconium salts e.g., aluminium chlorohydrates or sesquichlorohydrates are widely used as antiperspirant active in antiperspirant composition. These actives have the effect of reducing perspiration, particularly when applied onto the underarm regions of the human body viz. the axilla.
- a drawback of the presence of the metal based antiperspirant active is that it may cause stains.
- These stains are particularly formed in the underarm region. These stains are formed when the fabric comes in contact with the antiperspirant composition while wearing and may remain on the fabric after washing. The stains become more intensive after several such wear and wash cycles and appear as yellow discoloration on fabrics.
- the stains of particular concern are the yellow discoloration which are produced when the antiperspirant composition reaches the textile during sweating along with the body secretions, particularly in the armpit region. In combination with the sweat the antiperspirant actives form a yellow stain. Further, in a normal machinewashing cycle this yellow stain is accentuated by washing, and the heat (electric dryer, ironing or pressing) can further accentuate the intensity of the coloring. Moreover, the yellowing can be transferred to other areas of the clothing during laundering of the clothing.
- the combination of materials that contribute to yellowing can be redeposited to other areas of the clothing during laundering.
- the yellowing is more noticeable on white or light-colored clothing, while particulate deposits and stiffness are prevalent on all types of fabrics.
- the problem of yellow discoloration is further aggravated when the antiperspirant composition includes unsaturated oils.
- current antiperspirant compositions also include natural oils for delivering skin care benefits.
- the natural oil includes unsaturated oils such as sunflower seed oil.
- US2014/093464 A1 discloses an antiperspirant composition including metal based antiperspirant active, nonionic surfactant and cationic surfactant.
- the present inventors have surprisingly found that when specific nonionic surfactant having a HLB value less than 12 and specific levels of cationic surfactant is included in an antiperspirant composition comprising a metal based antiperspirant active, then the stain on clothing caused by the interaction of body oils with antiperspirant composition having a metal based antiperspirant active or those caused by the interaction of the antiperspirant active with the oils present in the composition is easily removed when the fabric is subsequently washed.
- the inventive anhydrous aerosol antiperspirant composition provides for reducing or eliminating the yellowing of clothing while still maintaining the effectiveness of the antiperspirant composition.
- the composition also provides for improving washability of stains and reducing the stiffness of the fabrics resulting from the deposition of the antiperspirant composition on fabrics. It was also found that the composition according to the present invention provides for reducing particulate build up on the fabrics on repeated wash wear, thus reducing the white marks on dark coloured/black fabrics.
- anhydrous aerosol antiperspirant composition comprising: (i) a metal based antiperspirant active;
- nonionic surfactant is selected from the group consisting of polyoxyethylene sorbitan alkyl esters (sold as Tween surfactants), fatty alcohol ethoxylates (sold as Brij surfactants), sorbitan monoester (sold as Span surfactants), alkyl polyglucosides, and Cs-Ci6 fatty alcohol glycoside.
- a non-ionic surfactant having an HLB value less than 12 and a cationic surfactant in an antiperspirant composition comprising a metal based antiperspirant active for minimizing the stains on the fabrics caused by antiperspirant composition.
- a method for minimizing the stains on the fabrics caused by antiperspirant composition comprising the step of (a) applying a composition according to the first aspect of the present invention on to a body part, which comes in contact with the fabric when worn by an individual, preferably the axilla followed by (b) washing, (c) preferably rinsing and (d) optionally drying the fabric.
- body oil refers to a clear, hypotonic biofluid produced by eccrine and apocrine glands located in the epidermis.
- Sweat is slightly acidic (pH range 4 - 6) and is composed mainly of water (99%), containing electrolytes (e.g., sodium, chloride, and potassium ions), urea, pyruvate, and lactate, but also proteins, peptides, amines, amino acids, and metal ions.
- electrolytes e.g., sodium, chloride, and potassium ions
- urea pyruvate
- lactate lactate
- proteins peptides, amines, amino acids, and metal ions.
- xenobiotics a variety of substances that are foreign to the body
- the term “fabric” applies to any type of cloth or textile comprising natural and/or synthetic materials.
- the fabrics useful in the present invention include, but are not limited to, woven, non-woven and knitted fabrics of natural fibers, synthetic fibers and mixtures of natural and synthetic fibers.
- Suitable fibers include, but are not limited to, fibers of cotton, linen, silk, wool, nylon, polyester, acrylic, rayon, acetate and mixtures thereof.
- preferred features of the invention apply equally to all aspects of the invention.
- the word “comprising” is intended to mean “including” but not necessarily “consisting of” or “composed of.” In other words, the listed steps or options need not be exhaustive.
- all percentages are percentages by weight, unless otherwise indicated.
- anhydrous aerosol antiperspirant composition having a metal based antiperspirant active, nonionic surfactant, and cationic surfactant.
- anhydrous aerosol antiperspirant composition which includes a non-ionic surfactant having a HLB value less than 12. More preferably the nonionic surfactant has an HLB value of less than 11, still more preferably less than 10.
- HLB refers to the "hydrophilic-lipophilic balance" of a molecule, such as a surfactant.
- the HLB number increases with increasing hydrophilicity.
- the HLB system is a semi-empirical method to predict what type of surfactant properties a molecular structure will provide.
- the HLB system is based on the concept that some molecules have hydrophilic groups, other molecules have lipophilic groups, and some have both.
- the HLB of a surfactant can be calculated according to Griffin WC: "Classification of Surface- Active Agents by ’HLB,’” Journal of the Society of Cosmetic Chemists 1 (1949): 311; and Griffin WC: “Calculation of HLB Values of Non-lonic Surfactants,” Journal of the Society of Cosmetic Chemists 5 (1954): 259.
- the HLB of a mixture of surfactants may be calculated by multiplying the proportion of each surfactant in the mixture by its HLB value and adding up the resulting values, as is known in the art.
- Non-limiting examples of nonionic surfactants (along with their HLB values indicated inside the brackets) which have a HLB value of less than 12, preferably less than 11 includes but is not limited to Glycol Distearate (1), Sorbitan Trioleate (1.8), Propylene Glycol Isostearate (2.5), Glycol Stearate (2.9), Sorbitan Sesquioleate (3.7), Glyceryl Stearate (3.8), Lecithin (4), Sorbitan Oleate (4.3), Sorbitan Monostearate NF (4.7 ), Sorbitan Stearate (4.7), Sorbitan Isostearate (4.7), Steareth-2 (4.9), Oleth-2 (4.9), Glyceryl Laurate (5.2), Ceteth-2 (5.3), PEG- 30 Dipolyhydroxystearate (5.5), Glyceryl Stearate SE (5.8), Sorbitan Stearate (and) Sucrose Cocoate (6), PEG-4 Dilaurate (6), Methy
- the non-ionic surfactant is selected from the group consisting of polyoxyethylene sorbitan alkyl esters, fatty alcohol ethoxylates, sorbitan monoester, alkyl polyglucosides and Cs to Ci6 fatty alcohol glycoside. More preferably where the non-ionic surfactant has an HLB of less than 11.0.
- the non-ionic surfactant is selected from the group consisting of polyoxyethylene sorbitan alkyl esters (sold as Tween surfactants), fatty alcohol ethoxylates (sold as Brij surfactants), sorbitan monoester (sold as Span surfactants), alkyl polyglucosides and Cs to Ci6 fatty alcohol glycoside. More preferably where the non-ionic surfactant has an HLB of less than 11.0.
- the nonionic surfactant for use in the present invention is selected from polyethylene glycol dodecyl ether (sold as Brij L4), Steareth-2 (sold as Brij S2), tri(oxyethylene) dodecyl ether (sold as EO3) or a combination of EO3 and hepta (oxyethylene) dodecyl ether (sold as EO7).
- the antiperspirant composition according to the present invention in addition to the nonionic surfactant already disclosed above may include additional nonionic surfactant with HLB value of less than 12, preferably the additional nonionic surfactant is a nonionic silicone surfactant.
- the nonionic silicone surfactant is a dimethicone based silicone surfactant.
- a dimethicone based silicone surfactant having an HLB value of less than 12 is a methyl substituted polyorganosiloxanes.
- Preferred additional nonionic silicone surfactant includes silicone copolyol where polyethylene glycol and polypropylene glycol are copolymerized with dimethicone either individually or together. These combinations may be either graft, block, or end terminated. Graft polymers are those where the EO or PO chains are attached at various points along the main silicone backbone. Block or end terminated polymers have the EO or PO chains at the end of the silicone backbone. Preferably the chains may be either mixed or homopolymers. The preferred number of repeating units is below 20 and most preferred below 18.
- the additional nonionic silicone surfactant is an alkyl dimethicone copolyol corresponding to the formula (I) below: wherein;
- Ri denotes a linear or branched, C1-C20, preferably C1-C16, alkyl group
- R3 denotes a hydrogen atom or linear or branched alkyl radical containing from 1 to 12 carbon atoms; a is an integer ranging from 1 to 500 b denotes an integer ranging from 1 to 500 n is integer ranging from 2 to 12, and preferably from 2 to 5 x denotes an integer ranging from 1 to 50 y denotes an integer ranging from 0 to 50 with the proviso that, when y is other than zero, the ratio x/y is greater than 1 , and preferably ranges from 2 to 11.
- R 4 denotes the group C m H2m-(-OC2H4-)s-(-OC3H 6 -)t-O-R5;
- the dimethicone based nonionic silicone surfactant may also include those under the general formula (III)
- Ri denotes a linear or branched, C1-C20, preferably C1-C16, alkyl group
- R 2 denotes the group: C n H2 n -(-OC2H4-)x-(-OC3H6-) y -O-R3;
- Rs denotes a hydrogen atom or linear or branched alkyl radical containing from 1 to 12 carbon atoms;
- R4 denotes C m H2 m - 5
- Re denotes a linear or branched, C1-C10, preferably C1-C5
- alkyl group a is an integer ranging from 1 to 500
- b denotes an integer ranging from 1 to 500
- c denotes an integer ranging from 0 to 500
- n is integer ranging from 2 to 12
- m is an integer ranging from 2 to 4
- x denotes an integer ranging from 1 to 50
- y denotes an integer ranging from 0 to 50 with the proviso that, when y is other than zero, the ratio x/y is greater than 1, and preferably ranges from 2 to 11.
- nonionic silicone surfactant is selected from non-limiting examples which includes Lauryl PEG-8-Dimethicone sold by Siltech Corporation under the tradename Silube J208-412 (HLB value 8 to 10), Lauryl-PEG-10-tris(trimethylsiloxy)silylethyldimethicone sold by Dow chemicals under the trade name Dowsil ES 5300 (HLB value 3), PEG/PPG-18/18 dimethicone (and) cyclopentasiloxane, bis-PEG/PPG-14/14Dimethicone (and) dimethicone, and more particularly the bis-PEG-14/PPG-14 dimethicone (and) cyclopentasiloxane (INCI name) mixture, such as the product sold by the Evonik under the trade name Abil EM 97, (HLB value 5), PEG/PPG-18/18 Dimethicone (and) cyclopentasiloxane, commercially available in a mixture with cyclopen
- the nonionic silicone surfactant may preferably be a PEG-x- Dimethicone with x ranging from 1 to 18, still preferably from 1 to 10.
- the nonionic surfactant is present in an amount ranging from 0.5 wt.% to 6 wt.% by weight of the composition, more preferably the nonionic surfactant is present in an amount ranging from 0.5 wt.% to 5 wt.%.
- Antiperspirant actives for use herein are selected from aluminium, zirconium, and mixed aluminium/zirconium salts, including both inorganic salts, salts with organic anions and complexes.
- Particularly preferred astringent salts are halohydrate salts, and especially chlorohydrate salts, optionally activated.
- the antiperspirant active is preferably free from zirconium.
- Cationic surfactant preferably has a quaternary ammonium group.
- the cationic surfactant is a quaternary ammonium compound which includes the organic ammonium compound with quaternary nitrogen atoms. They are produced by the conversion of tertiary amines with alkylation agents, such as, e.g., methyl chloride, benzyl chloride, dimethyl sulfate, dodecyl bromide, as well as ethylene oxide.
- R 1 represents a saturated or unsaturated, linear, branched, or cyclic alkyl or aryl group having 8 to 24 carbon atoms, more preferably R 1 represents a saturated, linear C to Cis alkyl group.
- R 2 represents a saturated or unsaturated, linear, branched, or cyclic substituted or nonsubstituted alkylene group having 1 to 10 carbon atoms and 0 to 5 hydroxy groups, more preferably the R 2 represents the group CH2CH2CH2-.
- R 3 , R 4 , R 5 independently of one another represent hydrogen, a Ci to C4 alkyl group, a C5 or Ce cycloalkyl group, an aryl group or a C2 to C4 hydroxy alkyl group, and X represents a monovalent anion, more preferably radicals R 3 , R 4 , R 5 each represent alkyl group, for example but not limited to methyl, ethyl, propyl, isopropyl and butyl groups. In particular methyl groups are preferred.
- compounds according to formula (IV) are those in which the monovalent anion X represents halide, for example chloride or bromide or one of the two groups CH3-O-SO3 (methosulfate) or CH3CH2-O-SO3 (ethosulfate).
- halide for example chloride or bromide or one of the two groups CH3-O-SO3 (methosulfate) or CH3CH2-O-SO3 (ethosulfate).
- the cationic surfactants include compound according to the Formula (IV) includes palmitamidopropyltrimonium chloride and commercially available under the trade name Varisoft®PATC (Ex. Evonik), behenamidopropyl ethyldimonium ethosulfate, such as is commercially available for example under the trade name Mackernium BAPDES from McIntyre, stearamidopropyl trimonium methosulfate, as is commercially available for example under the trade name Catigene SA-70 from Stepan Company and/or undecylamidopropyltrimonium methosulfate, such as is available for example under the trade name Rewocid UTM 185 from Evonik.
- Varisoft®PATC Ex. Evonik
- behenamidopropyl ethyldimonium ethosulfate such as is commercially available for example under the trade name Mackernium BAPDES from McIntyre
- Varisoft®PATC is composed of 60% palmitamidopropyltrimonium chloride in 40% propylene glycol as solvent.
- a mixture of palmitamidopropyltrimonium chloride and a fatty alcohol (cetearyl alcohol) can be used, trade name Tego Care CE 40.
- the cationic surfactant has a structure represented by
- the cationic surfactant is included in an amount ranging from 0.1 wt.% to 4 wt.% by weight of the composition, more preferably in an amount ranging from 0.5 wt.% to 4 wt.% by weight of the composition.
- the antiperspirant composition comprises at least 0.3 wt.%, 0.5 wt.%, still preferably at least 0.8 wt.%, still preferably at least 1 wt.%, most preferably at least 1.5 wt.% of the cationic surfactant, but typically not more than 4 wt.%, more preferably not more than 3.75 wt.%, still preferably not more than 3.6 wt.%, not more than 3. 5 wt.%, most preferably not more than 3 wt.% of cationic surfactant based on the weight of the antiperspirant composition.
- the weight ratio of metal based antiperspirant active to the cationic surfactant is preferably 20:1 to 30:1 , more preferably 10:1 to 15:1 , most preferably 5:1 to 8:1.
- the weight ratio of the cationic surfactant to the nonionic surfactant is preferably ranging from 1 :1 to 1:10, more preferably 1:1 to 1:5, , still more preferably 1:1 to 3:1 , also preferably from 1 :1.5: 1:10, 1:1.5 : 1 :5, and most preferably from 1 :1 to 1:3 or 1 :1.5 to 1:3. It was surprising found that when the weight. % of the cationic surfactant is lower than the weight % of the nonionic surfactant in the anhydrous aerosol antiperspirant composition it provides for improved stain removal performance.
- antiperspirant composition preferably includes an emulsifier.
- emulsifier it is meant that the ingredient ensures that two immiscible liquids (for example oil and water) can mix to form an emulsion.
- Nonionic emulsifiers include fatty alcohols (e.g., cetyl or stearyl alcohol), partial fatty acid esters of polyhydric alcohols with saturated fatty acids (e.g., glycerol monostearate), partial fatty acid esters of polyhydric alcohols with unsaturated fatty acids (eg., glycerol monooleate, pentaerythritol monooleate), also polyoxyethylene esters of fatty acids (eg., polyoxyethylene stearate), polymerization products of ethylene oxide and propylene oxide with fatty alcohols (fatty alcohol polyglycol ether) or fatty acids (fatty acid ethoxylates). It is preferred that the anhydrous aerosol antiperspirant composition according to the present invention includes minimal or no nonionic emulsifier with an HLB of more than 12.
- the anhydrous aerosol antiperspirant composition according to the present invention includes less than 10 wt.% nonionic emulsifier, more preferably less than 5 wt.% nonionic emulsifier, still preferably less than 3 wt.%, still more preferably less than 1 wt.%, and most preferably the anhydrous aerosol antiperspirant composition has 0 wt.% nonionic emulsifier.
- nonionic emulsifier includes fatty alcohols such as stearyl alcohol, octyldodecanol, and cetyl alcohol.
- non-ionic emulsifier do not count among the nonionic surfactants according to the invention.
- antiperspirant composition preferably includes an unsaturated oil.
- the anti-perspirant composition according to the first aspect of the present invention includes an unsaturated oil having an iodine value of at least 70, preferably at least 80, still preferably at least 90, and also more preferably at least 100.
- the composition of the invention is substantially anhydrous.
- anhydrous is meant that the composition comprises no added water.
- the composition may comprise some water that gets included in the composition from the ingredients formulated to form the composition.
- the water content may also be as a result of the ingress of water from the moisture in the atmosphere which reaches an equilibrium with the components of the composition.
- the composition comprises less than less than 10 wt.%, preferably less than 5 wt.%, furthermore preferably less than 2 wt.%, and most preferably less than 0.5 wt.% by weight of the composition.
- the anhydrous aerosol composition includes a structurant.
- the structurant includes disteardimonium hectorite, propylene carbonate and more preferably a combination thereof.
- the amount of structurant present in the composition ranges from 0.01 wt.% to 4 wt.%, still preferably 0.01 wt.% to 1 wt.%, still preferably from 0.01 wt.% to 0.8 wt.%, still preferably from 0.01 wt.% to 0.7 wt.%.
- antioxidant compound in disclosed antiperspirant composition may include an antioxidant compound.
- Suitable and conventional antioxidants which are generally included in such compositions may be added in the present invention.
- Such antioxidants are selected from one or more of butyl hydroxy toluene or its derivatives, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate (sold as Tinogard TT), or dilauryl thiodipropionate (sold as Tinogard DA), Tetramethylhydroxypiperidinol) Citrate (sold as Tinogard Q), tocopherol acetate or ascorbic acid and its derivatives.
- composition of the invention is preferably delivered as a composition in aerosol form, spray form or in stick form or roll on.
- the antiperspirant composition is in an anhydrous composition.
- wax fatty alcohols have been employed as gellant for many years, and are effective for the purpose of gelling, the resultant product is rather ineffective at improving the visual appearance of skin, and in particular underarm skin, to which the composition has been applied.
- This problem has been solved by including ameliorating materials for example, di or polyhydric humectants and/or a triglyceride oil.
- the composition according to the first aspect of the present invention provides for minimizing of staining or yellow discoloration on a fabric in contact with the antiperspirant composition which is noticeable after laundering the fabric. More preferably from the first wash. This is seen through a lower b value of the fabric after washing the fabric.
- Anhydrous antiperspirant aerosol composition as shown in Table 1 below were prepared:
- Example 1 Effect of presence of a non-ionic surfactant in accordance to the present invention
- composition according to the present invention having a metal based antiperspirant active was studied for the effect of inclusion of specific levels of non-ionic surfactant and cationic surfactant as in Table 1 , and the cleaning efficacy was measured as given in the protocol below.
- Stain removal measurement In the study, a 12 X 12 cm 2 fabric swatch was taken. In this study 0.3 g of APA base was premixed with 50 mg of model sebum and applied on a circular area corresponding to 33 cm 2 . 0.5 mL of ionic sweat was spread uniformly over the fabric swatch. Swatches were incubated at 45°C for 12 h. The swatches were washed with Persil Non-Bio liquid detergent in Front load washing machine (make: IFB SX). Study was done with 4 replicate swatches for each sample. The swatches were dried in Tumble drier (IFB Tumble drier).
- Treated fabric swatches were washed in an IFB front loader washing machine, programmed for soak (30 minutes), wash and two rinses. A wash load of approximate 2 ⁇ 0.1 kg including polycotton fabrics and the treated swatches were placed into the washing machine. The hardness of water was maintained at 24 FH water (2:1, Ca: Mg). 36 grams of Persil Non-Bio Liquid detergent was added in the dosing chamber at a dosage level of 3gpL. The swatches were dried using tumble dryer (IFB) at hot air mode (45°C) for 90 minutes. The dried swatches were ironed according to the nature of the fabric as stipulated by iron box manufacturer (Black + Decker Steam Iron).
- IFB tumble dryer
- the data in the table 1 shows that the composition according to the present invention (Ex 3) where the antiperspirant composition includes a non-ionic surfactant (polyethylene glycol dodecyl ether) having HLB less than 12 at claimed levels and a cationic surfactant (cetyl trimethyl ammonium bromide) at claimed levels according to the present invention has a lower Db* value as compared to a comparative compositions (Ex A and Ex B) where Ex A does not have a non-ionic surfactant and cationic surfactant, and Ex B has either a cationic surfactant or nonionic surfactant but not both. All of these compositions were found to have a higher Db* value as compared to the compositions according to the invention.
- a non-ionic surfactant polyethylene glycol dodecyl ether
- a cationic surfactant cetyl trimethyl ammonium bromide
- composition according to the invention provides for minimizing the stains on clothing caused by the interaction of body oils with antiperspirant composition having a metal based antiperspirant active or those caused by the interaction of the antiperspirant active with the oils present in the aerosol antiperspirant composition which is anhydrous and is better in performance as compared to the comparative composition.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP23177877 | 2023-06-07 | ||
| PCT/EP2024/065185 WO2024251655A1 (en) | 2023-06-07 | 2024-06-03 | Antiperspirant composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4724152A1 true EP4724152A1 (en) | 2026-04-15 |
Family
ID=86731927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP24731512.0A Pending EP4724152A1 (en) | 2023-06-07 | 2024-06-03 | Antiperspirant composition |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4724152A1 (en) |
| MX (1) | MX2025014481A (en) |
| WO (1) | WO2024251655A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102009010665A1 (en) | 2009-02-27 | 2010-09-16 | Beiersdorf Ag | Use of charged surfactants to reduce textile staining by antiperspirants |
| MX2023006760A (en) * | 2020-12-11 | 2023-06-19 | Unilever Ip Holdings B V | An antiperspirant composition. |
-
2024
- 2024-06-03 WO PCT/EP2024/065185 patent/WO2024251655A1/en not_active Ceased
- 2024-06-03 EP EP24731512.0A patent/EP4724152A1/en active Pending
-
2025
- 2025-12-02 MX MX2025014481A patent/MX2025014481A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024251655A1 (en) | 2024-12-12 |
| MX2025014481A (en) | 2026-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10111818B2 (en) | Use of charged surfactants for reducing textile staining by antiperspirants | |
| AU2022287610B2 (en) | An antiperspirant composition | |
| AU2021393976B2 (en) | An antiperspirant composition | |
| WO2024251655A1 (en) | Antiperspirant composition | |
| EP4536173B1 (en) | Antiperspirant composition | |
| EP4452192B1 (en) | Antiperspirant composition | |
| CN116600769A (en) | Antiperspirant Composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20251112 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| INTG | Intention to grant announced |
Effective date: 20260713 |